These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16184246)

  • 1. [Prolactinomas and bone mineral density in men].
    Naliato EC; Farias ML; Violante AH
    Arq Bras Endocrinol Metabol; 2005 Apr; 49(2):183-95. PubMed ID: 16184246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas.
    Andereggen L; Frey J; Andres RH; Luedi MM; Widmer HR; Beck J; Mariani L; Christ E
    Sci Rep; 2021 Mar; 11(1):5122. PubMed ID: 33664388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and magnitude of osteopenia in patients with prolactinoma.
    Kayath MJ; Lengyel AM; Vieira JG
    Braz J Med Biol Res; 1993 Sep; 26(9):933-41. PubMed ID: 8298528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density and bone turnover in hyperprolactinaemia of various origins.
    Zadrozna-Sliwka B; Bolanowski M; Kałuzny M; Syrycka J
    Endokrynol Pol; 2007; 58(2):116-22. PubMed ID: 17578827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactinomas.
    Glezer A; Bronstein MD
    Endocrinol Metab Clin North Am; 2015 Mar; 44(1):71-8. PubMed ID: 25732643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin decline as a signal for hyperprolactinemia onset prior to prolactinoma diagnosis in hypogonadal men.
    Rudman Y; Duskin-Bitan H; Richter I; Tsvetov G; Masri-Iraqi H; Akirov A; Shimon I
    Andrology; 2023 Oct; 11(7):1398-1407. PubMed ID: 36897756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of not treating hyperprolactinemia.
    Sanfilippo JS
    J Reprod Med; 1999 Dec; 44(12 Suppl):1111-5. PubMed ID: 10649820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vertebral fractures in males with prolactinoma.
    Mazziotti G; Porcelli T; Mormando M; De Menis E; Bianchi A; Mejia C; Mancini T; De Marinis L; Giustina A
    Endocrine; 2011 Jun; 39(3):288-93. PubMed ID: 21479837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Decreased bone mineral density in pre-menopause women with prolactinoma].
    Bussade I; Naliato EC; Mendonça LM; Violante AH; Farias ML
    Arq Bras Endocrinol Metabol; 2007 Dec; 51(9):1522-7. PubMed ID: 18209896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of osteopenia in men with prolactinoma.
    Naliato EC; Farias ML; Braucks GR; Costa FS; Zylberberg D; Violante AH
    J Endocrinol Invest; 2005 Jan; 28(1):12-7. PubMed ID: 15816365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis in men with hyperprolactinemic hypogonadism.
    Greenspan SL; Neer RM; Ridgway EC; Klibanski A
    Ann Intern Med; 1986 Jun; 104(6):777-82. PubMed ID: 3706929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Follow-Up of Primary Medical Versus Surgical Treatment of Prolactinomas in Men: Effects on Hyperprolactinemia, Hypogonadism, and Bone Health.
    Andereggen L; Frey J; Andres RH; El-Koussy M; Beck J; Seiler RW; Christ E
    World Neurosurg; 2017 Jan; 97():595-602. PubMed ID: 27773859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hyperprolactinemia on osteoporotic fracture risk in premenopausal women.
    Vartej P; Poiana C; Vartej I
    Gynecol Endocrinol; 2001 Feb; 15(1):43-7. PubMed ID: 11293923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 22-year-old man with severe osteoporosis due to prolactinoma.
    Dandinoğlu T; Akarsu S; Tekin L; Arbal S; Dinçer U
    J Clin Rheumatol; 2013 Sep; 19(6):341-3. PubMed ID: 23965473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperprolactinemia Due to Prolactinoma has an Adverse Impact on Bone Health with Predominant Impact on Trabecular Bone: A Systematic Review and Meta-Analysis.
    Nagendra L; Dutta D; Mondal S; Kapoor N; Joshi A; Bhattacharya S
    J Clin Densitom; 2024; 27(1):101453. PubMed ID: 38064881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopenia in children and adolescents with hyperprolactinemia.
    Galli-Tsinopoulou A; Nousia-Arvanitakis S; Mitsiakos G; Karamouzis M; Dimitriadis A
    J Pediatr Endocrinol Metab; 2000 Apr; 13(4):439-41. PubMed ID: 10777000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient guide to hyperprolactinemia diagnosis and treatment.
    Hoffman AR; Melmed S; Schlechte J
    J Clin Endocrinol Metab; 2011 Feb; 96(2):35A-6A. PubMed ID: 21296988
    [No Abstract]   [Full Text] [Related]  

  • 18. The epidemiology of prolactinomas.
    Ciccarelli A; Daly AF; Beckers A
    Pituitary; 2005; 8(1):3-6. PubMed ID: 16411062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperprolactinemia unrelated to prolactinoma].
    Krysiak R; Okopień B
    Wiad Lek; 2014; 67(2 Pt 1):101-11. PubMed ID: 25764785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of osteopenia in premenopausal women with various sellar tumors.
    Zhao Y; Gan X; Luo P; He Q; Guo Q; Zhang L; Zhang X; Zhang X; Fei Z
    Gynecol Endocrinol; 2012 Dec; 28(12):945-8. PubMed ID: 22553947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.